Bristol Myers Squibb Co. (BMY)

54.28 -0.38 (-0.70%) USD  |  NYSE  |  Dec 23, 16:00
54.21 -0.07 (-0.13%) Pre-Market: 05:33
More

Bristol Myers Squibb SG&A Expense (TTM): 7.222B for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for BMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Amgen, Inc. 6.976B
Gilead Sciences, Inc. 5.886B
Johnson & Johnson 23.38B
Eli Lilly & Co. 10.39B
Regeneron Pharmaceuticals, Inc. 2.717B